SCHEMBL22011034

SCHEMBL22011034

CC(C)Oc1c(Br)cccc1C=O

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA1 P00915 1/20 0.43
CA2 P00918 1/20 0.43
ALDH1A3 P47895 1/20 0.39
CYP2A6 P11509 1/20 0.38
SRC P12931 1/20 0.37
LMNA P02545 3/20 0.37
MEN1 O00255 1/20 0.37
THRB P10828 1/20 0.37
BLM P54132 1/20 0.37
KMT2A Q03164 1/20 0.37
TDP1 Q9NUW8 1/20 0.37
ERN1 O75460 4/20 0.36
TLR2 O60603 1/20 0.36
TLR1 Q15399 1/20 0.36
TLR6 Q9Y2C9 1/20 0.36
ALDH1A1 P00352 2/20 0.35
TSHR P16473 1/20 0.35
TRIM24 O15164 1/20 0.35
TRIM33 Q9UPN9 1/20 0.35
CYP1A2 P05177 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25897354 0.82 CA1 (0.38) CA1CA2CYP2A6SRCLMNA
SCHEMBL2557622 0.82 CA1 (0.41) CA1CA2CYP2A6SRCKMT2A
SCHEMBL29766670 0.82 CA1 (0.38) CA1CA2CYP2A6SRCLMNA
SCHEMBL15331103 0.81 CA1 (0.41) CA1CA2CYP2A6SRCLMNA
SCHEMBL1748658 0.80 SRC (0.45) CA1CA2ALDH1A3SRCLMNA
SCHEMBL1598490 0.80 TSHR (0.50) CA1CA2ALDH1A3SRCLMNA
SCHEMBL25706407 0.80 CA1 (0.43) CA1CA2SRCMEN1KMT2A
SCHEMBL1293351 0.79 CA1 (0.61) CA1CA2CYP2A6SRCLMNA
SCHEMBL2555877 0.79 CA1 (0.39) CA1CA2SRCLMNAMEN1
SCHEMBL13332341 0.79 ERN1 (0.47) CA1CA2ALDH1A3SRCLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2020099341-A1 ANTIBIOTIC COMPOUNDS, METHODS OF MANUFACTURING THE SAME, PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME AND USES THEREOF DEBIOPHARM INTERNATIONAL S.A. (CH) 2020-05-22 WO disclosed